Brief: Cue Biopharma Says Preclinical Milestone Triggers $7.5 Mln Payment Under Boehringer Deal
07/04/2026 14:50
April 7 (Reuters) - Cue Biopharma Inc CUE.O: CUE BIOPHARMA INC - PRECLINICAL MILESTONE TRIGGERS $7.5 MILLION PAYMENT TO CUE BIOPHARMA EXPECTED IN MAY 2026 - SEC FILING Source text: [ID:n0001193125-26-144569] Further company coverage: CUE.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cue Biopharma
See all newsU.S. STOCKS ON THE MOVE-Insmed, Marvell, Meta
US STOCKS ON THE MOVE-Meta, Marvell Technology, Insmed
U.S. STOCKS ON THE MOVE-Accenture, Arhaus, Alkermes
Cue Biopharma surges after positive results from mid-stage study for CUE-221
Brief: Cue Biopharma Announces Positive Topline Results From Cue-221 Phase 2 Study In Chronic Spontaneous Urticaria